Cure My Disease

Don't miss your cure!

 Log in / Sign up

New drug trial offers hope for controlling tough epilepsy

NCT ID NCT07219407

Recruiting now Disease control Sponsor: Rapport Therapeutics Inc. Source: ClinicalTrials.gov ↗

Summary

This study is testing the long-term safety and effectiveness of an investigational drug called RAP-219 for adults with focal epilepsy that doesn't respond well to current medications. It follows 30 participants who have already completed a related short-term study to see how well the drug controls seizures over a longer period. The main goal is to check for side effects while also measuring how much it reduces seizure frequency and improves quality of life.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EPILEPSY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Baylor College of Medicine

    RECRUITING

    Houston, Texas, 770300, United States

  • Cleveland Clinic Foundation

    RECRUITING

    Cleveland, Ohio, 44195, United States

  • Consultants in Epilepsy and Neurology, PLLC

    RECRUITING

    Boise, Idaho, 83702, United States

  • Mayo Clinic

    RECRUITING

    Rochester, Minnesota, 55905, United States

  • NYU Langone Comprehensive Epilepsy Center

    RECRUITING

    New York, New York, 10016, United States

  • University of Pennsylvania - Department of Neurology

    RECRUITING

    Philadelphia, Pennsylvania, 19104, United States

  • Vanderbilt University Medical Center

    RECRUITING

    Nashville, Tennessee, 37232, United States

Conditions

Explore the condition pages connected to this study.

EPILEPSY FOCAL EPILEPSY FOCAL SEIZURE FOCAL-ONSET SEIZURE REFRACTORY FOCAL EPILEPSY SEIZURE